← All sarcoma trials
Recruiting nowAges 15 Years and up

Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone

Sponsor: Mayo Clinic · NCT05033288 on ClinicalTrials.gov ↗

Conditions studied

Bone SarcomaChondrosarcomaChordomaEwing Sarcoma of BonePelvic Rhabdomyosarcoma

What it tests

  • Electronic Health Record Reviewother
  • Quality-of-Life Assessmentother

Where it's running3 sites

  • Mayo Clinic in Arizona

    Scottsdale, Arizona 85259

    Recruiting now
  • Mayo Clinic in Florida

    Jacksonville, Florida 32224-9980

    Recruiting now
  • Mayo Clinic in Rochester

    Rochester, Minnesota 55905

    Recruiting now
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* Males and females \>= 15 years of age
* Newly diagnosed, histologic confirmation of pelvic chordoma, chondrosarcoma, osteosarcoma, Ewing sarcoma with bone involvement, rhabdomyosarcoma (RMS) with bone involvement or non-RMS soft tissue sarcoma with bone involvement
* No evidence of distant sarcoma metastases as determined by clinical examination and any form of imaging
* Eastern Cooperative Oncology Group (ECOG) performance status (PS) =\< 2
* Patients capable of childbearing must agree to use adequate contraception
* Ability to complete questionnaire(s) by themselves or with assistance
* Ability to provide written informed consent
* Chemotherapy per institutional guidelines is allowed

Exclusion Criteria:

* Patients receiving palliative treatment
* Recurrent disease
* Males and females \< 15 years of age
* Previous radiation therapy to the site of the sarcoma or area surrounding it such that it would be partially or completely encompassed by the radiation volume needed to treat the current sarcoma. In other words, treatment on this study would require re-irradiation of tissues
* Patients with distant sarcoma metastases
* Benign pelvic bone histologies
* Any of the following:

  * Pregnant women
  * Nursing women
  * Men or women of childbearing potential who are unwilling to employ adequate contraception

Updated 2026-03-13 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.